Step by Step

INTRODUCTION

Preimplation Genetic Diagnosis and Screening: Risks and Benefits

QUIZ

EVALUATION

CERTIFICATE

INTRODUCTION

Credit Hours: CME 1.00

Target Audience:

Gynecologists and women's health practitioners who care for patients during their reproductive years.

Educational Objectives:

Upon completion of this activity, participants should be able to: Upon completion of this activity, participants should be able to:

  • Recognize the difference between preimplantation genetic screening (PGS) and preimplantation genetic diagnosis (PGD)
  • Discuss potential indications for PGS.
  • Discuss risks and benefits associated with PGS

Contact: For questions or technical difficulties, please contact us at infertility@magee.edu

Suggested Additional Reading:

  1. ACOG Practice Bulletin No. 163: Screening for Fetal Aneuploidy. Obstet Gynecol. 2016;127(5):e123-137.
  2. Ethics Committee of American Society for Reproductive M. Use of preimplantation genetic diagnosis for serious adult onset conditions: a committee opinion. Fertility and sterility. 2013;100(1):54-57.
  3. Scott RT, Jr., Upham KM, Forman EJ, et al. Blastocyst biopsy with comprehensive chromosome screening and fresh embryo transfer significantly increases in vitro fertilization implantation and delivery rates: a randomized controlled trial. Fertility and sterility. 2013;100(3):697-703.

Authors:
Marie Menke, MD, MPH — Assistant Professor, Division of Reproductive Endocrinology and Infertility, Department of Obstetrics, Gynecology and Reproductive Sciences, Magee-Womens Hospital, UPMC
Dr. Menke receives grant support from NIH.
No other members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Pittsburgh School of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Each physician should only claim credit commensurate with the extent of their participation in the activity.

The University of Pittsburgh is an affirmative action, equal opportunity institution.